HomeARQT • NASDAQ
add
Arcutis Biotherapeutics Inc
Previous close
$13.69
Day range
$12.67 - $13.85
Year range
$6.99 - $16.20
Market cap
1.50B USD
Avg Volume
2.26M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 71.36M | 427.58% |
Operating expense | 72.09M | -0.50% |
Net income | -10.79M | 83.72% |
Net profit margin | -15.12 | 96.91% |
Earnings per share | -0.09 | 87.50% |
EBITDA | -7.17M | 88.20% |
Effective tax rate | -3.09% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 227.96M | -16.15% |
Total assets | 348.89M | 2.20% |
Total liabilities | 191.35M | -24.28% |
Total equity | 157.54M | — |
Shares outstanding | 118.64M | — |
Price to book | 10.22 | — |
Return on assets | -4.85% | — |
Return on capital | -6.03% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -10.79M | 83.72% |
Cash from operations | -748.00K | 98.67% |
Cash from investing | 34.88M | 156.08% |
Cash from financing | -97.41M | -198.11% |
Net change in cash | -63.52M | -233.02% |
Free cash flow | -10.02M | 69.94% |
About
Founded
2016
Headquarters
Website
Employees
342
